Amid the second wave of COVID-19 in India and the shortage of vaccine doses from the two domestic manufacturers, Covishield by Serum Institute of India and Covaxin by...
At least 36 people in the US developed a rare blood disorder, called thrombocytopenia, after receiving either Pfizer-BioNTech or Moderna vaccine, the only two vaccines authorised...